{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:15:52Z","timestamp":1757704552721,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13643-017-0457-z","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T12:10:45Z","timestamp":1490098245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical, behavioural and pharmacogenomic factors influencing the response to levothyroxine therapy in patients with primary hypothyroidism\u2014protocol for a systematic review"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8428-1724","authenticated-orcid":false,"given":"Rosie","family":"Dew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onyebuchi","family":"Okosieme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Eligar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishrat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"457_CR1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bmj.322.7289.798","volume":"322","author":"A Price","year":"2001","unstructured":"Price A, Weetman AP. Screening for central hypothyroidism is unjustified. BMJ. 2001;322:798.","journal-title":"BMJ"},{"key":"457_CR2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(04)15696-1","volume":"363","author":"CG Roberts","year":"2004","unstructured":"Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004;363:793\u2013803.","journal-title":"Lancet"},{"key":"457_CR3","unstructured":"BTA. UK guidelines for the use of thyroid function tests. 2006. Available from: http:\/\/www.british-thyroid-association.org\/sandbox\/bta2016\/uk_guidelines_for_the_use_of_thyroid_function_tests.pdf . [cited 19th Nov 2015]."},{"key":"457_CR4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2458-9-132","volume":"9","author":"AL Mitchell","year":"2009","unstructured":"Mitchell AL, Hickey B, Hickey JL, et al. Trends in thyroid hormone prescribing and consumption in the UK. BMC Public Health 1994. 2009;9:132.","journal-title":"BMC Public Health 1994"},{"key":"457_CR5","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1210\/jc.2011-3399","volume":"97","author":"B Biondi","year":"2012","unstructured":"Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab. 2012;97:2256\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"457_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526\u201334.","journal-title":"Arch Intern Med"},{"key":"457_CR7","first-page":"107","volume":"43","author":"JV Parle","year":"1993","unstructured":"Parle JV, Franklyn JA, Cross KW, et al. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract. 1993;43:107\u20139.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"457_CR8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/qjmed\/hcq222","volume":"401","author":"OE Okosieme","year":"2011","unstructured":"Okosieme OE, Belludi G, Spittle K, et al. Adequacy of thyroid hormone replacement in a general population. QJM. 2011;401(5):395\u2013401.","journal-title":"QJM"},{"issue":"4","key":"457_CR9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1210\/jc.2008-1696","volume":"94","author":"LL Somwaru","year":"2009","unstructured":"Somwaru LL, Arnold AM, Joshi N, et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab. 2009;94(4):1342\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"457_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","volume":"174","author":"PN Taylor","year":"2014","unstructured":"Taylor PN, Iqbal A, Minassian C, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174:32\u20139.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"457_CR11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2009-1625","volume":"95","author":"RW Flynn","year":"2010","unstructured":"Flynn RW, Bonellie SR, Jung RT, et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1):186\u201393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"457_CR12","first-page":"4278","volume":"81","author":"B Uzzan","year":"2011","unstructured":"Uzzan B, Campos J, Cucherat M, et al. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab. 2011;81(12):4278\u201389.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"457_CR13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.amjmed.2006.04.034","volume":"120","author":"DC Bauer","year":"2007","unstructured":"Bauer DC, Rodondi N, Stone KL, et al. Thyroid hormone use, hyperthyroidism and mortality in older women. Am J Med. 2007;120(4):343\u20139.","journal-title":"Am J Med"},{"key":"457_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","volume":"12","author":"LH Duntas","year":"2002","unstructured":"Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12:287\u201393.","journal-title":"Thyroid"},{"key":"457_CR15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.158.13.1413","volume":"158","author":"AT Dugbartey","year":"1998","unstructured":"Dugbartey AT. Neurocognitive aspects of hypothyroidism. Arch Intern Med. 1998;158:1413\u20138.","journal-title":"Arch Intern Med"},{"key":"457_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1022985902253","volume":"4","author":"E Fliers","year":"2003","unstructured":"Fliers E, Wiersinga WM. Myxedema coma. Rev Endocr Metab Disord. 2003;4:137\u201341.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"457_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1524-4733.2007.00232.x","volume":"11","author":"C McMillan","year":"2008","unstructured":"McMillan C, Bradley C, Razvi S, et al. Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ. Value Health. 2008;11(2):285\u201394.","journal-title":"Value Health"},{"issue":"5","key":"457_CR18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2265.2002.01654.x","volume":"57","author":"P Saravanan","year":"2002","unstructured":"Saravanan P, Chau WF, Roberts N, et al. Psychological well-being in patients on \u2018adequate\u2019 doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf). 2002;57(5):577\u201385.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"457_CR19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12020-013-9886-1","volume":"44","author":"S Vigario Pdos","year":"2013","unstructured":"Vigario Pdos S, Vaisman F, Coeli CM, et al. Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life-a Brazilian multicentre study. Endocrine. 2013;44(2):434\u201340. Epub 2013\/02\/02.","journal-title":"Endocrine"},{"key":"457_CR20","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1517\/14656566.2011.600307","volume":"12","author":"OE Okosieme","year":"2011","unstructured":"Okosieme OE. Thyroid hormone replacement: current status and challenges. Expert Opin Pharmacother. 2011;12:2315\u201328.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"457_CR21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/er.2013-1083","volume":"35","author":"B Biondi","year":"2014","unstructured":"Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433\u2013512.","journal-title":"Endocr Rev"},{"issue":"3","key":"457_CR22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1210\/jc.2007-1067","volume":"93","author":"M Torlontano","year":"2008","unstructured":"Torlontano M, Durante C, Torrente I, et al. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts l-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab. 2008;93(3):910\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"457_CR23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"key":"457_CR24","unstructured":"Sch\u00fcnemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from: www.handbook.cochrane.org ."},{"key":"457_CR25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias). J Clin Epidemiol. 2011;64:407\u201315.","journal-title":"J Clin Epidemiol"},{"issue":"7414","key":"457_CR26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. Epub 2003\/09\/06.","journal-title":"BMJ"},{"issue":"323","key":"457_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","volume":"14","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;14(323):101\u20135.","journal-title":"BMJ"},{"key":"457_CR28","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from: http:\/\/handbook.cochrane.org . Accessed 5 Sept 2016."},{"key":"457_CR29","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre TCC; 2014. Available from: http:\/\/tech.cochrane.org\/revman\/about-revman-5 . Accessed 5 Sept 2016."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:07:46Z","timestamp":1498381666000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-017-0457-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1186\/s13643-017-0457-z","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"article-number":"60"}}